These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24886550)

  • 1. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
    Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
    Watanabe K; Ishii H; Kiyomi F; Terasaki Y; Hebisawa A; Kawabata Y; Johkoh T; Sakai F; Kondoh Y; Inoue Y; Azuma A; Suda T; Ogura T; Inase N; Homma S;
    Respir Investig; 2019 Jul; 57(4):312-320. PubMed ID: 30981683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.
    Kinoshita Y; Watanabe K; Ishii H; Kushima H; Hamasaki M; Fujita M; Nabeshima K
    Virchows Arch; 2019 Jan; 474(1):97-104. PubMed ID: 30327882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation of elastic fibres in idiopathic pulmonary fibrosis: a whole-slide image analysis and comparison with pleuroparenchymal fibroelastosis.
    Kinoshita Y; Watanabe K; Ishii H; Kushima H; Fujita M; Nabeshima K
    Histopathology; 2017 Dec; 71(6):934-942. PubMed ID: 28718917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ishii H; Nabeshima K; Watanabe K
    Histol Histopathol; 2021 Mar; 36(3):291-303. PubMed ID: 33315234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
    Suzuki Y; Yoshimura K; Enomoto Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    Sci Rep; 2018 Sep; 8(1):14074. PubMed ID: 30232390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis.
    Enomoto N; Suda T; Kono M; Kaida Y; Hashimoto D; Fujisawa T; Inui N; Nakamura Y; Imokawa S; Funai K; Chida K
    Respir Med; 2013 Oct; 107(10):1608-16. PubMed ID: 23993151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Miyamura T; Ikeda T; Ueda Y; Yoshida Y; Kushima H; Ishii H
    Respir Investig; 2022 Jul; 60(4):562-569. PubMed ID: 35398003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
    Suzuki Y; Fujisawa T; Sumikawa H; Tanaka T; Sugimoto C; Kono M; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2020 Sep; 171():106078. PubMed ID: 32917352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.
    Shiiya H; Nakajima J; Date H; Chen-Yoshikawa TF; Tanizawa K; Handa T; Oto T; Otani S; Shiotani T; Okada Y; Matsuda Y; Shiraishi T; Moroga T; Minami M; Funaki S; Chida M; Yoshino I; Hatachi G; Uemura Y; Sato M
    Surg Today; 2021 Aug; 51(8):1276-1284. PubMed ID: 33576927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum latent transforming growth factor-β binding protein 4 as a novel biomarker for idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ikeda T; Kushima H; Fujita M; Nakamura T; Nabeshima K; Ishii H
    Respir Med; 2020 Sep; 171():106077. PubMed ID: 32658840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in Idiopathic Pleuroparenchymal Fibroelastosis.
    Kato M; Sasaki S; Kurokawa K; Nakamura T; Yamada T; Sasano H; Arano N; Komura M; Ihara H; Nagashima O; Shiota S; Takahashi F; Takahashi K
    Respiration; 2019; 97(4):319-328. PubMed ID: 30522096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of the radiological indeterminate for usual interstitial pneumonia pattern on the diagnosis of idiopathic pulmonary fibrosis.
    Inomata M; Jo T; Kuse N; Awano N; Tone M; Yoshimura H; Moriya A; Bae Y; Terada Y; Furuhata Y; Kumasaka T; Ushiwata A; Harada A; Terasaki Y; Takeuchi M; Sugiura H; Takemura T; Izumo T
    Respir Investig; 2021 Jan; 59(1):81-89. PubMed ID: 32868263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.
    Shioya M; Otsuka M; Yamada G; Umeda Y; Ikeda K; Nishikiori H; Kuronuma K; Chiba H; Takahashi H
    Can Respir J; 2018; 2018():6043053. PubMed ID: 30186537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia.
    Sugino K; Ono H; Shimizu H; Kurosawa T; Matsumoto K; Ando M; Mori K; Tsuboi E; Homma S; Kishi K
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33681342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.
    Kono M; Tsunoda T; Ikeda S; Yagi S; Hirama R; Watanuki M; Oshima Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Investig; 2023 Mar; 61(2):210-219. PubMed ID: 36773509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis.
    Oda T; Ogura T; Kitamura H; Hagiwara E; Baba T; Enomoto Y; Iwasawa T; Okudela K; Takemura T; Sakai F; Hasegawa Y
    Chest; 2014 Nov; 146(5):1248-1255. PubMed ID: 25367470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ishii H; Kushima H; Johkoh T; Yabuuchi H; Fujita M; Nabeshima K; Watanabe K
    Sci Rep; 2020 Jan; 10(1):306. PubMed ID: 31941942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.
    Hayashi H; Nei T; Abe S; Saito Y; Kokuho N; Atsumi K; Fujita K; Saito T; Tanaka T; Gemma A; Azuma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):35-40. PubMed ID: 32476820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.